Innovative biomarker discovery and validation



Genomic or protein-based biomarker? 

It depends on the question you’re asking – ask BioXpedia as a first step!



AH Seminar Day

6 September 2018, Copenhagen

Presentation by CEO Mogens Kruhøffer in session: Molecular Techniques for Complex Analysis

Medical Innovation Day

5th October 2018, Aarhus

Symposium Extracellular Vesicles

11 October 2018, Aalborg

Bioagora - Immunotherapy biomarkers

27th November 2018, Copenhagen

4th Immunotherapy Symposium

29 November 2018, Aarhus

Follow us on LinkedIn to get weekly updates


What scientists are saying about BioXpedia

“Current research deals intensively with analysis of blood and urine to identify novel biomarkers. One of the challenges is to develop sensitive and specific methods to identify disease-associated molecules in complex clinical samples. I am convinced that the new sensitive methods for measuring biomarker signatures will become an important tool in biomarker research.”     

Lars Dyrskjøt Andersen,

Professor, Dept. of Molecular Medicine (MOMA), Aarhus University Hospital

”We are used to measuring 1-2 relations at a time, while this type of panels make it possible to broaden the analysis, so that we at one time fast and precisely may measure the content of several substances and proteins in a biopsy. If this screening method holds its promise, it is fantastic. It might turn out to be of huge importance to guiding us and giving an overview of the identification process to find disease markers” 

Kristian Stengaard-Pedersen

Professor, Dept of Rheumatology, Clinical medicine at Aarhus University

The Fast Track to precision medicine!

Our technologies

  • Time-, cost-, and sample effective
  • Rapid and reproducible
  • High multiplex level
  • Automated workflow
  • Maximum reproducibility and efficiency
  • Effective QC tools


Proximity Extension Assay – protein biomarkers

High-Throughput qPCR – miRNA, RNA and SNP

Extraction and sample preparation

nanoString – DNA, RNA and protein



BioXpedia A/S is a contract research laboratory founded in 2016 by CEO Mogens Kruhøffer to provide high quality cost effective targeted biomarker screening to pre-clinical and clinical researchers. Our main focus is on the identification of new clinically useful biomarkers for patient stratification, treatment response, and discovery of potential drug targets.

Get In Touch

Palle Juul-Jensens boulevard 82
DK-8200 Aarhus N
Phone: +45 70 23 10 01
Bussines Hours: 8 am- 16 pm M-F